Insight into the Molecular Interaction of Cloxyquin (5-chloro-8-hydroxyquinoline) with Bovine Serum Albumin: Biophysical Analysis and Computational Simulation

doi:10.3390/ijms21010249

Paper

Insight into the Molecular Interaction of Cloxyquin (5-chloro-8-hydroxyquinoline) with Bovine Serum Albumin: Biophysical Analysis and Computational Simulation

Published Dec 30, 2019 · Kamonrat Phopin, Waralee Ruankham, Supaluk Prachayasittikul

International Journal of Molecular Sciences

Q1 SJR score

33

Citations

0

Influential Citations

Open Access PDF Full text Semantic Scholar

Abstract

Cloxyquin is a potential therapeutic compound possessing various bioactivities, especially antibacterial, antifungal, cardioprotective, and pain relief activities. Herein, the interaction mechanism between cloxyquin and bovine serum albumin (BSA) has been elucidated in order to fulfill its pharmacokinetic and pharmacodynamic gaps essential for further development as a therapeutic drug. Multi-spectroscopic and biophysical model analysis suggested that cloxyquin interacts with BSA via a static process by ground-state complex formation. Its binding behavior emerged as a biphasic fashion with a moderate binding constant at the level of 104 M−1. Thermodynamic analysis and molecular docking simulation concurrently revealed that hydrophobic interaction is a major driving force for BSA–cloxyquin complexation. Binding of cloxyquin tends to slightly enlarge the monomeric size of BSA without a significant increase of aggregate fraction. Cloxyquin preferentially binds into the fatty acid binding site 5 (FA5) of the BSA via hydrophobic interaction amongst its quinoline scaffold and Phe550, Leu531, and Leu574 residues of BSA. The quinoline ring and hydroxyl moiety of cloxyquin also form the π–π interaction and the hydrogen bond with Phe506. Our data indicate a potential function of serum albumin as a carrier of cloxyquin in blood circulation.

In Vitro Study

Study Snapshot

Cloxyquin interacts with bovine serum albumin (BSA) via a static process, suggesting potential as a blood circulation carrier for its various bioactivities.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Insight into the Molecular Interaction of Cloxyquin (5-chloro-8-hydroxyquinoline) with Bovine Serum Albumin: Biophysical Analysis and Computational Simulation

References

Discovery of novel halogenated 8‐hydroxyquinoline‐based anti‐MRSA agents: In vitro and QSAR studies

Cloxyquin, a halogenated 8-hydroxyquinoline derivative, shows promising anti-MRSA activity and antioxidant properties, making it a promising candidate for further development as a novel anti-MRSA agent.

BSA interaction and DNA cleavage studies of anti-bacterial benzothiazol-2-yl-malonaldehyde

BTM shows better antibacterial activity against gram-negative bacteria Pseudomonas aeruginosa than other bacterial stains, with a moderate binding and DNA cleavage potential.

BSA binding and antibacterial studies of newly synthesized 5,6-Dihydroimidazo[2,1-b]thiazole-2-carbaldehyde.

The synthesized 5,6-Dihydroimidazo[2,1-b]thiazole-2-carbaldehyde (ITC) shows good antibacterial activity and interacts with bovine serum albumin (BSA) at site III.

Repurposing of Nitroxoline Drug for the Prevention of Neurodegeneration.

NQ, a quinoline-based compound, may prevent neurodegeneration by promoting cell survival and reducing apoptosis through the SIRT1-FOXO3a signaling pathway.

Ciprofloxacin-supported chitosan/polyphosphate nanocomposite to bind bovine serum albumin: Its application in drug delivery

The developed CIP@CH-TW/TPP nanocomposite effectively delivers drugs to targeted sites by binding to bovine serum albumin, improving drug releasing efficiency by 61-78% compared to native chitosan.

Citations

Structural interaction relationship of six edible flavonoids with CYP3A4 based on spectroscopic and computer simulation

Quercetin has the strongest binding capacity with CYP3A4, followed by hyperoside, isoquercitrin, quercetin-7-O-glucoside, rutin, and quercetin-3-O-sophoroside, which change the amino acid microenvironment

Synthesis, Characterization, and BSA Binding Properties of Carboxylated Merocyanine-Based Fluorophores

Carboxylated merocyanine-based fluorophores exhibit UV-A-to-blue absorption and blue-to-green fluorescence emission, with strong interactions with BSA protein via a static mechanism.

A New Hetero‐Bimetallic [Fe(III)‐Mn(I)] Complex as a Dual Modality, Theranostic Tool for Photoactivated Anticancer Therapy

The novel hetero-bimetallic Fe(III)-Mn(I) complex is a dual-modality theranostic tool for photoactivated anticancer therapy, producing hydroxyl radicals and CO release when activated by visible light.

Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2- yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies.

The interaction between 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin is moderate to strong, suggesting potential benefits for further development as a therapeutic agent.

Structural and in vitro anticancer properties of the kaempferol–lactoferrin complex

The lactoferrin-kaempferol complex shows synergistic anticancer properties, inhibiting HeLa cell proliferation through hydrophobic interactions and hydrogen bonding.

Functional evaluation of novel chromon derivative compounds for recognition of G-quadruplex structure

Novel chromon derivative compounds A and C, and their borondifluoride complexes B and D, show potential as selective and potent G-quadruplex binders, expanding the options for G-quadruplex targeting ligands.

Multiple spectroscopic and computational studies on binding interaction of 2-phenylamino-4-phenoxyquinoline derivatives with bovine serum albumin.

Compounds (1) and (2) bind to bovine serum albumin at site III, forming stable complexes with moderate binding affinities, primarily through hydrogen bonding and van der Waals forces.